| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.013 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 7e-05 | 1 |